Sign Up

Have an account?

Sign In

Don't have account,

Forgot Password

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.


Have an account?

Sorry, you do not have permission to ask a question, You must login to ask a question.

Need An Account,

Please briefly explain why you feel this question should be reported.

Please briefly explain why you feel this answer should be reported.

Please briefly explain why you feel this user should be reported.

Search
Ask A Question

Bio-technology

Share
Followers
488 Answers
251 Questions
Home/Applications & Awareness in Technology/Bio-technology/Page 24
  1. Asked: July 11, 2024In:

    How does biotechnology help in development of modern agriculture?

    Advait Deshmukh
    Advait Deshmukh Begginer

    Biotechnology has played a significant role in the development of modern agriculture, providing numerous benefits and advancements. Here are some ways in which biotechnology has contributed to the progress of agriculture: Crop Improvement: Genetic engineering techniques allow for the introduction ofRead more

    Biotechnology has played a significant role in the development of modern agriculture, providing numerous benefits and advancements. Here are some ways in which biotechnology has contributed to the progress of agriculture:

    1. Crop Improvement:
      • Genetic engineering techniques allow for the introduction of desirable traits, such as disease resistance, drought tolerance, and improved nutritional value, into crop plants.
      • This has led to the development of genetically modified (GM) crops that can thrive in challenging environmental conditions and exhibit higher yields.
    2. Pest and Disease Management:
      • Biotechnology has enabled the creation of crops that produce their own natural insecticides, reducing the need for chemical pesticides.
      • The development of biopesticides, which are derived from natural sources like bacteria or fungi, provides an eco-friendly alternative to synthetic pesticides.
    3. Livestock Productivity Enhancement:
      • Biotechnological tools, such as genetic selection and cloning, have been used to improve the genetic traits of livestock, leading to higher milk and meat production, better feed efficiency, and enhanced disease resistance.
      • Biotechnology also plays a role in developing vaccines and treatments for livestock diseases, improving animal health and welfare.
    4. Biofuel Production:
      • Biotechnology has facilitated the development of biofuels, which are produced from renewable biomass sources, such as agricultural waste, energy crops, and algae.
      • This has contributed to the diversification of energy sources and the reduction of greenhouse gas emissions from the transportation sector.
    5. Soil and Water Management:
      • Biotechnology has enabled the creation of microorganisms and enzymes that can improve soil fertility, enhance nutrient cycling, and increase water-use efficiency in agricultural systems.
      • Biotechnological applications in water management include the development of water-saving irrigation systems and the remediation of contaminated water.
    6. Diagnostic and Analytical Tools:
      • Biotechnology has provided advanced diagnostic tools and analytical methods to identify plant and animal diseases, detect food contaminants, and monitor environmental conditions, enabling more informed decision-making in agricultural practices.
    7. Sustainable Agriculture:
      • Biotechnology supports the development of sustainable agricultural practices, such as precision farming, integrated pest management, and the production of biofertilizers and biopesticides, which can reduce the environmental impact of agriculture.

    The integration of biotechnology in modern agriculture has led to increased crop yields, improved nutritional quality, reduced reliance on harmful chemicals, and enhanced sustainability, making it a crucial driver of agricultural development and food security.

    See less
  2. Asked: July 9, 2024In: ,

    What career paths can I choose after completing bsc Biotechnology?

    Alina Khan
    Alina Khan Begginer

    With a BSc in Biotechnology, you may pursue a variety of professional options in a number of different sectors. Typical career choices include the following: 1. Research Scientist: Developing new technologies, goods, or procedures via research in labs, colleges, or private research institutes. 2. BiRead more

    With a BSc in Biotechnology, you may pursue a variety of professional options in a number of different sectors. Typical career choices include the following:

    1. Research Scientist: Developing new technologies, goods, or procedures via research in labs, colleges, or private research institutes.

    2. Biotechnologist: Using biotechnological concepts to create new goods or enhance existing ones, biotechnologists operate in sectors like medicines, agriculture, food processing, and environmental conservation.

    3. Quality Control/Quality Assurance Officer: Making sure that goods, often in the food or pharmaceutical sectors, are of the highest caliber and comply with legal requirements.

    4. Bioinformatics Specialist: Utilizing software and computational tools to analyze biological data, especially in the fields of proteomics, genetics, and genomics.

    5. Medical Laboratory Technologist: Conducting laboratory procedures to support illness detection, management, and prevention.

    6. Biomedical Engineer: Using engineering concepts to create and develop equipment and technologies for medical use.

    7. Environmental Biotechnologist: Engaged in waste management, bioremediation, or environmental conservation initiatives.

    8. Biotechnology Sales and Marketing: promoting biotech goods or services, offering clients technical assistance, or creating marketing plans.

    9. Regulatory Affairs Specialist: Guaranteeing adherence to legal mandates in sectors like medicine or technology.

    10. Teaching and Academic Research: Going back to school to get an MSc or PhD and working in academia as a researcher or professor.

    11. Entrepreneurship: Founding your own biotech business or consulting firm, with a concentration on specialized markets like bioinformatics services, tailored medicine, or biotech goods.

    Depending on your interests and area of expertise within biotechnology, each career path provides distinct chances for influence and success.

    See less
  3. Asked: July 9, 2024In:

    Gene Therapy

    Mihir Jain
    Mihir Jain Begginer

    Genome editing, the process of modifying the DNA sequence of an organism, has raised significant ethical concerns due to its potential implications. Here are some of the key ethical concerns surrounding genome editing: Safety and Unintended Consequences: Genome editing techniques, such as CRISPR, haRead more

    Genome editing, the process of modifying the DNA sequence of an organism, has raised significant ethical concerns due to its potential implications. Here are some of the key ethical concerns surrounding genome editing:

    1. Safety and Unintended Consequences:
      • Genome editing techniques, such as CRISPR, have the potential to introduce unintended genetic changes that could have unforeseen and potentially harmful consequences.
      • There are concerns about the long-term effects of genetic modifications, both on the individual and on future generations.
    2. Equity and Access:
      • Genome editing technology is often expensive and may not be equally accessible to all individuals or communities.
      • This raises concerns about the potential for widening health disparities and creating a “genetic divide” between those who can access the technology and those who cannot.
    3. Eugenics and Genetic Enhancement:
      • Genome editing could theoretically be used to selectively eliminate or enhance certain genetic traits, leading to concerns about the potential for a new form of eugenics.
      • There are debates around the ethical boundaries of using genome editing for enhancement purposes, such as improving physical, cognitive, or behavioral traits.
    4. Informed Consent and Autonomy:
      • Individuals or their parents/guardians may not fully understand the long-term implications and risks associated with genome editing, making it difficult to obtain truly informed consent.
      • Concerns arise about the autonomy and decision-making rights of individuals, especially when it comes to modifications that could impact future generations.
    5. Human Dignity and the “Commodification” of Life:
      • Some argue that genome editing could lead to the “commodification” of human life, where individuals are seen as malleable products to be engineered rather than unique and inherently valuable beings.
      • This raises concerns about the potential erosion of human dignity and the intrinsic value of human life.

    These ethical concerns highlight the complex and multifaceted nature of genome editing. Ongoing discussions and debates within the scientific community, policymakers, ethicists, and the public are crucial to ensure that the development and application of genome editing technology are guided by ethical principles and responsible oversight.

    See less
  4. Asked: June 26, 2024In:

    Explain why India is considered a land of opportunities in the field of biotechnology. Also, discuss India's preparedness to become a leading bio-manufacturing hub.

    Aliya Sharma
    Aliya Sharma Begginer

    India is the third-largest biotechnology market in the Asia-Pacific region and one of the top twelve globally. The nation controls 3% of the worldwide biotechnology market. The Indian economy grew from US$ 70.2 billion in 2020 to US$ 80.12 billion in 2021, growing at 14.13%, and is targeted to reachRead more

    India is the third-largest biotechnology market in the Asia-Pacific region and one of the top twelve globally. The nation controls 3% of the worldwide biotechnology market. The Indian economy grew from US$ 70.2 billion in 2020 to US$ 80.12 billion in 2021, growing at 14.13%, and is targeted to reach $150 billion by 2025 and $270-300 billion by 2030. The factors that make India a land of opportunities in the field of biotechnology include:

    • High-performing segments: India offers strong capability in contract manufacturing, research, and clinical trials, and is home to the most US FDA-approved plants globally outside of the US. It is one of the biggest suppliers of low-cost drugs and vaccines in the world.
    • Domestic consumer demand: Healthcare is one of the fastest growing sectors in India, driven by a huge population, rising middle class, and an increasing prevalence of lifestyle diseases, such as heart disease and diabetes. It calls for investment in biotechnology research and development.
    • Increasing overseas demand: In order to contain healthcare costs, multinational companies are leveraging generics and biosimilars, and India has poised itself as a hub to deliver affordable access to innovative and inclusive healthcare solutions.
    • Thriving startup ecosystem: The total number of biotechnology startups has increased from 50 in 2010 to 5365 in 2021. These are estimated to reach 10,000 by 2025.
    • Skilled human capital: Recognising the potential of human capital in this sector, India established a Biotechnology Industrial Training Programme in 1993, under which the Department of Biotechnology and Bioinformatics was created in a very large number of institutions. Therefore, India has leverage of a large reservoir of scientific human resources in the field.
    • Favorable policies: The government’s focus on increasing health expenditure, the Production Linked Incentive Scheme for Pharmaceuticals for Atmanirbhar Bharat, and emphasis on biofuel is attracting R&D in the sector.

    India’s preparedness to make itself a leading global biotechnology hub can be understood through the following:

    • National Biotechnology Development Strategy 2021-25: It aims to strengthen the research ecosystem across the country to become a USD 150 billion economy by 2025.
    • The New Drugs and Clinical Trials Rules, 2019: To create a streamlined legal framework for the biopharmaceutical market to reduce costs, approval timelines and cut bureaucratic red tape.
    • Budgetary allocation: In the Union Budget 2022-23, the Department of Biotechnology was allotted Rs. 2,581 crore (US$ 343.56 million) for developing basic infrastructure, genetic engineering, technologies and bioinformatics, agriculture biotechnology, and training skilled professionals.
    • Biotechnology infrastructure: Biotechnology parks and incubators have been created across the country. The government has supported 9 Biotech Parks and 60 Bio-incubators and 51 Biotech-Kisan hubs have been created.
    • International Cooperation: The Department of Biotechnology has partnered with Cancer Research UK for research in making cancer medicines cheaper. Further, India has established the first Clean Energy International Incubator under Mission Innovation. It has also partnered with countries like Finland and France for development in biotechnology.

    Although the government is enthusiastic about supporting the biotechnology industry, it is facing some challenges as well. For instance, the government’s Genetic Engineering Appraisal Committee is facing difficulties getting approval for genetically modified crop field trials. There are also concerns about the environmental impact of India’s pharmaceutical industries. Also, the timelines and regulatory steps for biotechnology drug approvals are not user-friendly. The government needs to resolve these challenges through mass awareness, consensus building, and setting up a regulatory regime in accordance with the developments in the field.

    See less
  5. Asked: June 26, 2024In:

    trial in revolutionizing What do you understand by 'Organ on Chips' (OoCs)? Bring out their potential to revolutionising the pharmaceutical sector.

    Sammi Bhargav
    Sammi Bhargav Begginer

    Organ-on-chips are microfluidic devices containing human cells that are used to mimic the environment in human organs, including blood flow and breathing movements, serving as synthetic environments in which to test new drugs. Donald E. Ingber developed the first human Organ-on-Chip model in 2010. IRead more

    Organ-on-chips are microfluidic devices containing human cells that are used to mimic the environment in human organs, including blood flow and breathing movements, serving as synthetic environments in which to test new drugs. Donald E. Ingber developed the first human Organ-on-Chip model in 2010. It was a ‘Lung-on-a-chip’ that mimicked biochemical aspects of the lung and its breathing motions. The potential of this technology in revolutionizing pharmaceutical developments:

    • Personalized treatment: If the cells are isolated from patients and used to create the bio-mimetic tissues, the resulting organ chips can be used to develop personalized therapies for individual patients.
    • Replacing animals for testing: The current scientific consensus is that animals mimic some human diseases well but not others. In cases where they cannot mimic a condition, a new drug that seems promising in pre-clinical studies is almost certainly bound to fail in human clinical trials. Also, this ensures an ethical approach.
    • Expediting the clinical trials: Bringing a new drug into the market is a long, expensive, and challenging process ridden with failure, especially because of regulations attached to clinical trials on animals and human beings. Organ-on-Chip would therefore help in expediting the process. Also, the cost of producing these chips is not too exorbitant.
    • Predicting the treatment outcomes: There has been a push towards developing new treatments and evaluating combinations of treatments. The researchers have successfully predicted the ability of a drug to treat or cause injury to an organ through this technology.
    • Safety of food and cosmetic products: To predict how specific organs will respond to exposure to potential chemical hazards found in foods, cosmetics, and/or dietary supplements with greater precision than other methods currently being used, such as cell-culture or animal-based tests.

    For more than a decade, scientists, pharmaceutical companies, and animal activists have been pushing regulators to include synthetic setups that mimic human diseases. Organ-on-a-Chip can be an answer to such demands.

    See less

Resources & Suggestions

Mains Answer Writing Latest Articles

On: April 18, 2025

Daily Answer Writing Practice Questions (18 April 2025)

Do you agree with the claim that indecision and risk aversion are prevalent issues in Indian bureaucracy? Support your answer with logical reasoning. (150 words) ऐसा कहा जाता है कि भारतीय नौकरशाही में अनिर्णय और जोखिम से बचने की प्रवृत्ति ...

On: April 18, 2025 Comments: 0

Strengthening India’s Cyber Defence

Rising Threats Digital Era Challenges: 2024 marks a significant rise in digital threats, particularly from AI and cyberattacks. Key Issues: Disinformation campaigns. Cyber fraud affecting daily life. Current Major Cyber Threats Ransomware Rampage: Over 48,000 instances of WannaCry ransomware detected ...

On: April 18, 2025 Comments: 0

भारत की साइबर सुरक्षा

बढ़ते खतरे कृत्रिम बुद्धिमत्ता (AI) और साइबर हमले: 2024 में AI और साइबर हमलों के खतरे में वृद्धि। महत्वपूर्ण अवसंरचना पर हमले: डिजिटल हमलों और दुष्प्रचार अभियानों की संभावना बढ़ी है। प्रमुख साइबर खतरें रैनसमवेयर का प्रकोप: 48,000 से अधिक ...

Explore Our Blog